EMA Recommends Extending Indications for Decitabine / Cedazuridine By Ogkologos - May 29, 2026 220 0 Facebook Twitter Google+ Pinterest WhatsApp New indication concerns a combination with venetoclax for the treatment of adult patients with newly diagnosed AML Source RELATED ARTICLESMORE FROM AUTHOR Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics with a favourable safety profile Anito-cel, a d-Domain BCMA CAR T-Cell, Induces Rapid, Deep, and Durable Responses in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Relacorilant MOST POPULAR FDA Approves Trastuzumab Deruxtecan for Any HER2-Positive Solid Cancer May 3, 2024 49-Year-Old Breast Cancer Patient Grateful She Didn’t Wait Until 50 for... June 7, 2019 Researchers Turn On PTEN Tumor-Suppressor Protein in Cancer Cells June 14, 2019 More Immunotherapy Options Approved for Treating Endometrial Cancer August 6, 2024 Load more HOT NEWS Merging the Histologic and Molecular Data Into an Integrated Score Significantly... Empoderar a las personas con cáncer: preguntas y respuestas con la... Mom Diagnosed With Breast Cancer Adopts Healthy Lifestyle To Reinvent Her... Adolescent and Young Adult Cancer Survivors Face More Co-morbidity in Later...
